(Q44866798)

English

Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease (English)

1 reference

Europe PubMed Central

7 December 2017

Epstein–Barr virus

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Kenneth G Lucas

1

1 reference

Europe PubMed Central

7 December 2017

Donna Salzman

2

1 reference

Europe PubMed Central

7 December 2017

Alejandro Garcia

3

1 reference

Europe PubMed Central

7 December 2017

Qi Sun

4

1 reference

Europe PubMed Central

7 December 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

100

1 reference

Europe PubMed Central

7 December 2017

9

1 reference

Europe PubMed Central

7 December 2017

1892-1901

1 reference

Europe PubMed Central

7 December 2017

Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

21 January 2018

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

21 January 2018

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

21 January 2018

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease in patients with previous infectious mononucleosis: 30 years' experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired lymphocyte function in untreated Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Hodgkin's disease and the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cytokines in classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20188

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20188

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44866798&oldid=2054719155"